SCHEMBL6738199

SCHEMBL6738199

O=c1c(C2=NS(=O)(=O)c3ccccc3N2)c(O)c2ccccc2n1Cc1cccnc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.66
HSD17B10 Q99714 1/20 0.66
NR1I2 O75469 1/20 0.51
CYP2C9 P11712 1/20 0.51
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.42
CASP6 P55212 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.42
ALOX12 P18054 1/20 0.42
GABRA1 P14867 3/20 0.42
GABRA5 P31644 3/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HTT P42858 1/20 0.41
PKM P14618 1/20 0.41
MAPK10 P53779 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233389 0.90 MAPK1 (0.69) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL1522581 0.89 MAPK1 (0.54) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL1523151 0.88 MAPK1 (0.59) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL1522882 0.88 MAPK1 (0.59) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL1379880 0.86 HSD17B10 (0.57) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL1522274 0.86 FEN1 (0.54) MAPK1HSD17B10NR1I2CYP2C9GABRA1
SCHEMBL6231912 0.85 MAPK1 (0.64) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL6733839 0.85 MAPK1 (0.68) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL6235315 0.84 MAPK1 (0.65) MAPK1HSD17B10NR1I2CYP2C9KDM4E
SCHEMBL6237190 0.84 MAPK1 (0.67) MAPK1HSD17B10NR1I2CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1535151-A Novel anti-infectives ʷ��˿�������ȳ�ķ���޹�˾ 2004-10-06 CN claimed
CN-1535151-A Novel anti-infectives ʷ��˿�������ȳ�ķ���޹�˾ 2004-10-06 CN disclosed
US-20040147739-A1 Novel anti-infectives SMITHKLINE BEECHAM CORPORATION 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147739-A1 Novel anti-infectives RPL5, RPL7, RPL35 MAPK1 3699/4885HSD17B10 1428/4885NR1I2 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.